Technical Analysis for PSTI - Pluristem Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 0.979 -1.00% -0.01
PSTI closed down 1.0 percent on Tuesday, March 19, 2019, on 2.42 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical PSTI trend table...

Date Alert Name Type % Chg
Mar 19 20 DMA Resistance Bearish 0.00%
Mar 19 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Mar 19 Narrow Range Bar Range Contraction 0.00%
Mar 19 NR7 Range Contraction 0.00%
Mar 19 Inside Day Range Contraction 0.00%
Mar 18 Fell Below 20 DMA Bearish -1.00%
Mar 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.00%
Mar 15 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.51%
Mar 15 Crossed Above 20 DMA Bullish -1.51%
Mar 14 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.53%

Older signals for PSTI ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Pluristem Therapeutics Inc., a bio-therapeutics company, engages in the research, development, and commercialization of standardized cell therapy products and related technologies for the treatment of life threatening diseases. The company's products are derived from human placenta that is a non-controversial, non-embryonic, and adult cell source. Its Placental adherent stromal cells are grown in the company's proprietary PluriX three-dimensional process that allows cells to grow in a natural environment. The company develops placenta expanded cells (PLX) and peripheral artery disease cells, an allogeneic therapeutic product that is in Phase-II clinical trials for the treatment of intermittent claudication, critical limb ischemia, and Buerger's disease. Its PLX product is developed for the treatment of muscle injury, bone marrow diseases, inflammatory bowel disease, and multiple sclerosis, as well as for pulmonary disorders, acute radiation syndrome, acute myocardial infarction, diabetic diastolic heart failure, neuropathic pain, inflammatory bowel disease, multiple sclerosis, and ischemic stroke for which the product is in various pre-clinical trials. Pluristem Therapeutics Inc. is also involved in the development and commercialization of a PLX cell-based product for the treatment of pulmonary arterial hypertension through its license agreement with the United Therapeutics Corporation. The company was formerly known as Pluristem Life Systems Inc. and changed its name to Pluristem Therapeutics Inc. in November 2007. Pluristem Therapeutics Inc. was founded in 2001 and is headquartered in Haifa, Israel.
Biotechnology Life Sciences Biology Pain Diseases Stem Cells Radiation Multiple Sclerosis Inflammatory Bowel Disease Pulmonary Arterial Hypertension Cell Therapy Peripheral Artery Disease Acute Myocardial Infarction Ischemic Stroke
Is PSTI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.52
52 Week Low 0.66
Average Volume 214,522
200-Day Moving Average 1.1579
50-Day Moving Average 1.0461
20-Day Moving Average 0.9881
10-Day Moving Average 0.9769
Average True Range 0.0387
ADX 18.85
+DI 17.7672
-DI 19.9191
Chandelier Exit (Long, 3 ATRs ) 0.9439
Chandelier Exit (Short, 3 ATRs ) 1.0361
Upper Bollinger Band 1.0339
Lower Bollinger Band 0.9423
Percent B (%b) 0.4
BandWidth 9.270317
MACD Line -0.0139
MACD Signal Line -0.017
MACD Histogram 0.0031
Fundamentals Value
Market Cap 95.43 Million
Num Shares 97.5 Million
EPS -0.32
Price-to-Earnings (P/E) Ratio -3.06
Price-to-Sales 0.00
Price-to-Book 6.15
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.01
Resistance 3 (R3) 1.01 1.00 1.00
Resistance 2 (R2) 1.00 0.99 1.00 1.00
Resistance 1 (R1) 0.99 0.99 0.99 0.99 1.00
Pivot Point 0.98 0.98 0.98 0.98 0.98
Support 1 (S1) 0.97 0.97 0.98 0.97 0.96
Support 2 (S2) 0.96 0.97 0.96 0.96
Support 3 (S3) 0.95 0.96 0.96
Support 4 (S4) 0.95